메뉴 건너뛰기




Volumn 152, Issue 4, 2006, Pages 684.e1-684.e9

Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: Findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TENECTEPLASE;

EID: 33748708210     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.07.005     Document Type: Article
Times cited : (43)

References (24)
  • 1
    • 0028918696 scopus 로고
    • Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators
    • Lee K.L., Woodlief L.H., Topol E.J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 91 (1995) 1659
    • (1995) Circulation , vol.91 , pp. 1659
    • Lee, K.L.1    Woodlief, L.H.2    Topol, E.J.3
  • 2
    • 0027164577 scopus 로고
    • Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis
    • Stevenson R., Ranjadayalan K., Wilkinson P., et al. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ 307 (1993) 349
    • (1993) BMJ , vol.307 , pp. 349
    • Stevenson, R.1    Ranjadayalan, K.2    Wilkinson, P.3
  • 3
    • 0032399908 scopus 로고    scopus 로고
    • Age-related trends in short-and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995)
    • Goldberg R.J., McCormick D., Gurwitz J.H., et al. Age-related trends in short-and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol 82 (1998) 1311
    • (1998) Am J Cardiol , vol.82 , pp. 1311
    • Goldberg, R.J.1    McCormick, D.2    Gurwitz, J.H.3
  • 4
    • 0027428865 scopus 로고
    • Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico (GISSI-2)
    • Maggioni A.P., Maseri A., Fresco C., et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The investigators of the gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico (GISSI-2). N Engl J Med 329 (1993) 1442
    • (1993) N Engl J Med , vol.329 , pp. 1442
    • Maggioni, A.P.1    Maseri, A.2    Fresco, C.3
  • 5
    • 15844429131 scopus 로고    scopus 로고
    • Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis
    • Paul S.D., O'Gara P.T., Mahjoub Z.A., et al. Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J 131 (1996) 710
    • (1996) Am Heart J , vol.131 , pp. 710
    • Paul, S.D.1    O'Gara, P.T.2    Mahjoub, Z.A.3
  • 6
    • 0034673974 scopus 로고    scopus 로고
    • Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years
    • Thiemann D.R., Coresh J., Schulman S.P., et al. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 101 (2000) 2239
    • (2000) Circulation , vol.101 , pp. 2239
    • Thiemann, D.R.1    Coresh, J.2    Schulman, S.P.3
  • 7
    • 20244376615 scopus 로고
    • Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group
    • Weaver W.D., Litwin P.E., Martin J.S., et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. J Am Coll Cardiol 18 (1991) 657
    • (1991) J Am Coll Cardiol , vol.18 , pp. 657
    • Weaver, W.D.1    Litwin, P.E.2    Martin, J.S.3
  • 8
    • 10244242679 scopus 로고    scopus 로고
    • Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global utilization of streptokinase and TPA for occluded coronary arteries trial
    • White H.D., Barbash G.I., Califf R.M., et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 94 (1996) 1826
    • (1996) Circulation , vol.94 , pp. 1826
    • White, H.D.1    Barbash, G.I.2    Califf, R.M.3
  • 9
    • 0033695759 scopus 로고    scopus 로고
    • Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The thrombolysis in myocardial infarction (TIMI) 14 Investigators
    • Antman E.M., Gibson C.M., de Lemos J.A., et al. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The thrombolysis in myocardial infarction (TIMI) 14 Investigators. Eur Heart J 21 (2000) 1944
    • (2000) Eur Heart J , vol.21 , pp. 1944
    • Antman, E.M.1    Gibson, C.M.2    de Lemos, J.A.3
  • 10
    • 0345578676 scopus 로고    scopus 로고
    • Combination reperfusion therapy with eptifibatide and reduced dose tenecteplase for ST-elevation myocardial infarction: results of the Integrilin and tenecteplase in acute myocardial infarction trial (INTEGRITI) phase II angiographic trial
    • Giugliano R.P., Roe M., Harrington R., et al. Combination reperfusion therapy with eptifibatide and reduced dose tenecteplase for ST-elevation myocardial infarction: results of the Integrilin and tenecteplase in acute myocardial infarction trial (INTEGRITI) phase II angiographic trial. J Am Coll Cardiol 14 (2003) 1251-1260
    • (2003) J Am Coll Cardiol , vol.14 , pp. 1251-1260
    • Giugliano, R.P.1    Roe, M.2    Harrington, R.3
  • 11
    • 0035897888 scopus 로고    scopus 로고
    • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
    • Topol E.J. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 357 (2001) 1905
    • (2001) Lancet , vol.357 , pp. 1905
    • Topol, E.J.1
  • 12
    • 0035949117 scopus 로고    scopus 로고
    • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction
    • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358 (2001) 605
    • (2001) Lancet , vol.358 , pp. 605
  • 13
    • 0038447936 scopus 로고    scopus 로고
    • Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
    • Wallentin L., Goldstein P., Armstrong P.W., et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 108 (2003) 135
    • (2003) Circulation , vol.108 , pp. 135
    • Wallentin, L.1    Goldstein, P.2    Armstrong, P.W.3
  • 14
    • 0035927938 scopus 로고    scopus 로고
    • Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
    • Montalescot G., Barragan P., Wittenberg O., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 (2001) 1895
    • (2001) N Engl J Med , vol.344 , pp. 1895
    • Montalescot, G.1    Barragan, P.2    Wittenberg, O.3
  • 15
    • 0035182788 scopus 로고    scopus 로고
    • The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable
    • Casterella P.J., Kereiakes D.J., Steinhubl S.R., et al. The platelet function dose-response to abciximab during percutaneous coronary revascularization is variable. Catheter Cardiovasc Interv 54 (2001) 497
    • (2001) Catheter Cardiovasc Interv , vol.54 , pp. 497
    • Casterella, P.J.1    Kereiakes, D.J.2    Steinhubl, S.R.3
  • 16
    • 0036272018 scopus 로고    scopus 로고
    • Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes
    • Becker R.C., Spencer F.A., Gibson M., et al. Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. Am Heart J 143 (2002) 753
    • (2002) Am Heart J , vol.143 , pp. 753
    • Becker, R.C.1    Spencer, F.A.2    Gibson, M.3
  • 17
    • 33644876597 scopus 로고    scopus 로고
    • Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial
    • Sabatine M.S., Morrow D.A., Montalescot G., et al. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation 112 (2005) 3846-3854
    • (2005) Circulation , vol.112 , pp. 3846-3854
    • Sabatine, M.S.1    Morrow, D.A.2    Montalescot, G.3
  • 18
    • 33645515458 scopus 로고    scopus 로고
    • Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
    • Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354 (2006) 1477-1488
    • (2006) N Engl J Med , vol.354 , pp. 1477-1488
    • Antman, E.M.1    Morrow, D.A.2    McCabe, C.H.3
  • 19
    • 3342901810 scopus 로고    scopus 로고
    • Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin
    • Montalescot G., Collet J.P., Tanguy M.L., et al. Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin. Circulation 110 (2004) 392-398
    • (2004) Circulation , vol.110 , pp. 392-398
    • Montalescot, G.1    Collet, J.P.2    Tanguy, M.L.3
  • 20
    • 0036554907 scopus 로고    scopus 로고
    • Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction
    • Baird S.H., Menown I.B., McBride S.J., et al. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J 23 (2002) 627
    • (2002) Eur Heart J , vol.23 , pp. 627
    • Baird, S.H.1    Menown, I.B.2    McBride, S.J.3
  • 21
    • 16644386970 scopus 로고    scopus 로고
    • Effect of age on the use of evidence-based therapies for acute myocardial infarction
    • Tran C.T., Laupacis A., Mamdani M.M., et al. Effect of age on the use of evidence-based therapies for acute myocardial infarction. Am Heart J 148 (2004) 834-841
    • (2004) Am Heart J , vol.148 , pp. 834-841
    • Tran, C.T.1    Laupacis, A.2    Mamdani, M.M.3
  • 22
    • 0035879694 scopus 로고    scopus 로고
    • Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2])
    • Spencer F.A., Goldberg R.J., Frederick P.D., et al. Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2]). Am J Cardiol 88 (2001) 107
    • (2001) Am J Cardiol , vol.88 , pp. 107
    • Spencer, F.A.1    Goldberg, R.J.2    Frederick, P.D.3
  • 23
    • 0034949105 scopus 로고    scopus 로고
    • Post-myocardial infarction risk stratification in elderly patients
    • Alexander K.P., Galanos A.N., Jollis J.G., et al. Post-myocardial infarction risk stratification in elderly patients. Am Heart J 142 (2001) 37
    • (2001) Am Heart J , vol.142 , pp. 37
    • Alexander, K.P.1    Galanos, A.N.2    Jollis, J.G.3
  • 24
    • 0028285795 scopus 로고
    • Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators
    • Aguirre F.V., McMahon R.P., Mueller H., et al. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators. Circulation 90 (1994) 78
    • (1994) Circulation , vol.90 , pp. 78
    • Aguirre, F.V.1    McMahon, R.P.2    Mueller, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.